Toggle Main Menu Toggle Search

Open Access padlockePrints

Development of substituted benzo[c]quinolizinium compounds as novel activators of the cystic fibrosis chloride channel

Lookup NU author(s): Dr Michael Gray, Professor Barry Argent


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Chloride channels play an important role in the physiology and pathophysiology of epithelia, but their pharmacology is still poorly developed. We have chemically synthesized a series of substituted benzo[c]quinolizinium (MPB) compounds. Among them, 6-hydroxy-7- chlorobenzo[c]quinolizinium (MPB-27) and 6-hydroxy-10- chlorobenzo[c]quinolizinium (MPB-07), which we show to be potent and selective activators of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel. We examined the effect of MPB compounds on the activity of CFTR channels in a variety of established epithelial and nonepithelial cell systems. Using the iodide efflux technique, we show that MPB compounds activate CFTR chloride channels in Chinese hamster ovary (CHO) cells stably expressing CFTR but not in CHO cells lacking CFTR. Single and whole cell patch clamp recordings from CHO cells confirm that CFTR is the only channel activated by the drugs. Ussing chamber experiments reveal that the apical addition of MPB to human nasal epithelial cells produces a large increase of the short circuit current. This current can be totally inhibited by glibenclamide. Whole cell experiments performed on native respiratory cells isolated from wild type and CF null mice also show that MPB compounds specifically activate CFTR channels. The activation of CFTR by MPB compounds was glibenclamide-sensitive and 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid-insensitive. In the human tracheal gland cell line MM39, MPB drugs activate CFTR channels and stimulate the secretion of the antibacterial secretory leukoproteinase inhibitor. In submandibular acinar cells, MPB compounds slightly stimulate CFTR-mediated submandibular mucin secretion without changing intracellular cAMP and ATP levels. Similarly, in CHO cells MPB compounds have no effect on the intracellular levels of cAMP and ATP or on the activity of various protein phosphatases (PP1, PP2A, PP2C, or alkaline phosphatase). Our results provide evidence that substituted benzo[c]quinolizinium compounds are a novel family of activators of CFTR and of CFTR-mediated protein secretion and therefore represent a new tool to study CFTR-mediated chloride and secretory functions in epithelial tissues.

Publication metadata

Author(s): Gray MA; Argent BE; Becq F; Zegarra-Moran O; Tarran R; Bulteau L; Derand R; Pereira MMC; McPherson MA; Rogier C; Joffre M; Sarrouilhe D; Mettey Y; Kammouni W; Figarella C; Verrier B; Gola M; Vierfond J-M; Galietta LJV; Dormer RL; Merten M; Metaye T; Chappe V; Marvingt-Mounir C

Publication type: Article

Publication status: Published

Journal: Journal of Biological Chemistry

Year: 1999

Volume: 274

Issue: 39

Pages: 27415-27425

Print publication date: 24/09/2011

ISSN (print): 0021-9258

ISSN (electronic):

Publisher: American Society for Biochemistry and Molecular Biology, Inc.


DOI: 10.1074/jbc.274.39.27415

PubMed id: 10488073


Altmetrics provided by Altmetric